PURPOSE
This study was conducted to determine whether recommendations from the Diab
etes Control and Complications Trial (DCCT) could be implemented in a large
pediatric population using a diabetes clinical nurse specialist program co
ordinator dedicated to intensive management.
METHODS
Patients' charts were reviewed to examine HbA(1c) levels from before the re
sults of the DCCT were published and again 1 year after the recommendations
were implemented. Patients who met the following criteria (N=124) were enr
olled: type 1 diabetes, less than 18 years old, followed at Yale for 1 year
prior to the results of the DCCT and 1 year after, and HbA(1c) level recor
ded in the medical chart.
RESULTS
HbA(1c) levels were significantly lower 1 year after implementing the DCCT
protocol; 3 years later these same patients improved even further as eviden
ced by another decrease in HbA(1c) levels. The patients were taking more in
sulin (more Ultralente and regular insulin and less NPH) and had an increas
ed number of injections at both the 1-year and 3-year follow-up points.
CONCLUSIONS
The DCCT protocol can be implemented in a large population of pediatric pat
ients with the help of a nurse who is dedicated and available to the patien
ts for ongoing adjustments and provides creative ways to overcome the barri
ers to achieving normoglycemia.